Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-17T07:48:04.491Z Has data issue: false hasContentIssue false

Differences in Hospital-Associated Multidrug-Resistant Organisms and Clostridium difficile Rates Using 2-Day versus 3-Day Definitions

Published online by Cambridge University Press:  10 May 2016

Adrijana Gombosev*
Affiliation:
Division of Infectious Diseases and Health Policy Research Institute, University of California–Irvine Health, Irvine, California
Salah E. Fouad
Affiliation:
Infection Prevention Program, Saddleback Memorial Medical Center, Laguna Hills, California
Eric Cui
Affiliation:
Division of Infectious Diseases and Health Policy Research Institute, University of California–Irvine Health, Irvine, California
Chenghua Cao
Affiliation:
Division of Infectious Diseases and Health Policy Research Institute, University of California–Irvine Health, Irvine, California
Leah Terpstra
Affiliation:
Division of Infectious Diseases and Health Policy Research Institute, University of California–Irvine Health, Irvine, California
Taliser R. Avery
Affiliation:
Department of Population Medicine, Harvard Medical School, and Harvard Pilgrim Health Care Institute, Boston, Massachusetts
Diane Kim
Affiliation:
Division of Infectious Diseases and Health Policy Research Institute, University of California–Irvine Health, Irvine, California
Hildy Meyers
Affiliation:
Disease Control and Epidemiology, Orange County Health Care Agency, Santa Ana, California
Michele Cheung
Affiliation:
Disease Control and Epidemiology, Orange County Health Care Agency, Santa Ana, California
Susan S. Huang
Affiliation:
Division of Infectious Diseases and Health Policy Research Institute, University of California–Irvine Health, Irvine, California
*
University of California–Irvine School of Medicine, Health Policy Research Institute, 100 Theory, Suite 110, Irvine, CA 92617 (agombose@uci.edu).
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

We surveyed infection prevention programs in 16 hospitals for hospital-associated methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci, extended-spectrum β-lactamase, and multidrug-resistant Acinetobacter acquisition, as well as hospital-associated MRSA bacteremia and Clostridium difficile infection based on defining events as occurring >2 days versus >3 days after admission. The former resulted in significantly higher median rates, ranging from 6.76% to 45.07% higher

Infect Control Hosp Epidemiol 2014;35(11):1417–1420

Information

Type
Concise Communication
Copyright
© 2014 by The Society for Healthcare Epidemiology of America. All rights reserved.